H M Friis

Publications (5)2.86 Total impact

• Article: [Support to Danish antibiotic policy].

  J J Christensen, H M Friis, O Heltberg, J O Jarløv, K T Jensen, T Højbjerg, P Kjaeldgaard, B Lundgren, N Mortensen, J K Møller, P Schouenborg, S S Schrøder, P Søgaard, H J Kolmos, H C Schønheyder
  Ugeskrift for laeger 03/2001; 163(8):1135.
• Article: Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units.

  A Fomsgaard, N Høiby, H M Friis, B Gahrn-Hansen, H J Kolmos, P Schouenborg, B Korsager, M Tvede, E Gutschik, A Bremmelgaard
  [show abstract] [hide abstract]
  ABSTRACT: The prevalence and antibiotic sensitivity patterns of bacteria collected consecutively from medical and surgical intensive care units (ICUs) and from hematology/oncology units in nine hospitals in Denmark were determined and compared to data collected simultaneously in 12 other European countries. Bacterial isolates from 794 Danish patients were tested and compared to 8,625 isolates from European patients. The minimal inhibitory concentrations of eight different antibiotics were determined using a microdilution plate. Similar to findings in European countries, the most common source of bacterial isolates in Danish units was the respiratory tract (49%), followed by blood (18%), urinary tract (14%) and surgical wounds (10%). Staphylococcus aureus was the most prevalent respiratory organism in Danish units, whereas Enterobacteriaceae and Pseudomonas aeruginosa dominated in other countries. In blood, Escherichia coli was most prevalent in Denmark while coagulase-negative staphylococci were predominant in other countries. Urinary tract isolates were dominated by Escherichia coli in both Denmark and the other countries, but Enterococcus faecalis and Pseudomonas aeruginosa were more frequently isolated in the other countries. Staphylococcus aureus was the most frequent wound isolate in Denmark, while Enterobacteriaceae other than Escherichia coli dominated in other European countries. Thus, in Denmark Escherichia coli and Staphylococcus aureus, followed by Pseudomonas aeruginosa and Klebsiella spp. (from ICUs) or Enterococcus spp. and Klebsiella spp. (from hematology/oncology units), are the most prominent pathogens in these units today. Indicator organisms of antibiotic consumption (Pseudomonas aeruginosa and methicillin-resistant coagulase-negative staphylococci and Staphylococcus aureus) were more frequent in other European countries than Denmark. In general the Danish isolates were more sensitive to antibiotics than the European isolates.(ABSTRACT TRUNCATED AT 250 WORDS)
  European Journal of Clinical Microbiology 05/1995; 14(4):275-81. · 2.86 Impact Factor
• Article: [Azithromycin--an exciting new antibiotic].

  H M Friis
  Ugeskrift for laeger 02/1995; 157(2):145.
• Article: [Antibiotic use in Denmark and its control].

  H M Friis
  Ugeskrift for laeger 09/1988; 150(32):1911-2.
• Article: [Consumption of antibiotics in Denmark after an information campaign].

  H M Friis
  Ugeskrift for laeger 09/1988; 150(32):1943-4.